CAMPAIGN 2012

Perry Lowballed Drug-Company Donations in Debate

Updated: September 13, 2011 | 6:13 p.m.
September 13, 2011 | 3:22 p.m.

Republican Gov. Rick Perry of Texas (Ben Sklar/Getty Images)

Texas Gov. Rick Perry received more than $28,000 from the pharmaceutical company that makes a vaccine used in the battle against cervical cancer, significantly more than the $5,000 he acknowledged in Monday night’s Republican debate in Florida.

During the debate, Perry was attacked by his Republican opponents for an executive order he issued in 2007 mandating that schoolgirls receive a vaccine against human papillomavirus, or HPV, the virus responsible for most cases of cervical cancer. Rep. Michele Bachmann, R-Minn., charged that Perry had received thousands of dollars in contributions from Merck Pharmaceuticals to mandate the use of a vaccine that only Merck produced.
 
Perry responded, “The company was Merck, and it was a $5,000 contribution that I had received from them. I raise about $30 million. And if you're saying that I can be bought for $5,000, I'm offended.”
 
The governor was right that he is known for being a prolific fundraiser (though he operates in a state with no contribution limits). But the claim that he had only received $5,000 from Merck is misleading, considering the sum of his donations from the company.

According to records from the Texas Ethics Commission compiled by the nonprofit National Institute on Money in State Politics, Perry received a total of $28,500 in contributions from Merck’s political action committee from 2002 to 2010. In 2006, the year before his executive order, he received $6,000, and in his most recent gubernatorial fundraising year, he received $5,000 — the closest numbers to the $5,000 he mentioned in the debate.

The institute first compiled a report on Merck’s contributions to Perry in February 2007, by which time Perry had already received $21,000 from the company. The largest donation was in 2004, between two election cycles, when Merck donated $10,000 to Perry’s political action committee.
 
Money is not his only tie to the pharmaceutical company. Perry’s former chief of staff, Mike Toomey, served as one of Merck’s three lobbyists in Texas at the time Perry signed the executive order. In the mid-2000s, Merck was lobbying for several states to pass laws mandating the use of Gardasil vaccine for girls over the age of 10. Between 2000 and 2006, the company spent $158,143 on its lobbying campaign in Texas, the fifth-largest amount spent in a state, according to the institute.

Perry’s campaign declined to discuss the discrepancy in the numbers. Instead, spokesman Mark Miner said, "Life was the governor's factor in this issue," and stressed that the executive order was never implemented. The Legislature voted to overturn the order, and Perry has said that he was motivated by his desire to prevent cancer deaths.

Get the latest news and analysis delivered to your inbox. Sign up for National Journal's morning alert, Wake-Up Call, and afternoon newsletter, The Edge. Subscribe here.


Leave A Comment
The National Journal Group has the right (but not the obligation) to monitor the comments and to remove any materials it deems inappropriate.
Comments powered by Disqus
Follow National Journal
Related Content
New Faces in the 113th Congress
2012 Election Results
Columns
Charlie Cook: The Cook Report

Republicans Should Go Easy on Obama, At Least in Public

May 16, 2013
As a tactical matter, a subterranean campaign will score more direct hits on the president.
Ronald Brownstein: Political Connections

How the White House Scandals Could Hurt Republicans, Too

May 16, 2013
By enraging the base and strengthening the faction least willing to compromise with Obama, the IRS and Benghazi affairs could hurt a GOP shot at the presidency.
Norm Ornstein: Washington Inside Out

Eric Cantor’s Caucus Thwarts His Push for an Alternative Agenda

May 16, 2013
Cantor has learned that the tea-party movement he helped foster won’t fall in line behind his efforts to push an alternative conservative agenda.
More Columns »